ReviewActa pharmaceutica Sinica. B2025

Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions.

Fang Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.